Generic Darvocet Cos.' Mass Action Jurisdiction Claim Denied

Law360, New York (March 29, 2013, 2:05 PM EDT) -- A California judge on Thursday found that McKesson Corp. and other pharmaceutical companies targeted over cardiac issues linked to generic versions of painkillers Darvocet and Darvon could not justify federal removal by claiming an individual case is part of a larger mass action.

Judge William Alsup found that the suit — one of many brought over purported injuries from the painkiller propoxyphene — did not meet the criteria for federal removal under the Class Action Fairness Act or federal question jurisdiction simply because the plaintiffs had...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Brandle et al v. McKesson Corporation et al


Case Number

3:12-cv-05970

Court

California Northern

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

November 20, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.